283 studies found for:    Open Studies | Bladder cancer
Show Display Options
Rank Status Study
1 Recruiting Adjuvant Radiation for High Risk Bladder Cancer
Conditions: Bladder Cancer;   Squamous Cell Carcinoma of the Bladder;   Stage III Bladder Cancer;   Stage IV Bladder Cancer;   Transitional Cell Carcinoma of the Bladder
Interventions: Radiation: 3D conformal radiation therapy;   Procedure: quality-of-life assessment;   Procedure: therapeutic conventional surgery
2 Recruiting Sirolimus, Cisplatin, and Gemcitabine Hydrochloride in Treating Patients With Bladder Cancer
Conditions: Recurrent Bladder Carcinoma;   Stage II Bladder Cancer;   Stage III Bladder Cancer;   Stage IV Bladder Cancer
Interventions: Drug: Cisplatin;   Drug: Gemcitabine Hydrochloride;   Other: Laboratory Biomarker Analysis;   Drug: Sirolimus;   Procedure: Therapeutic Conventional Surgery
3 Unknown  Standard Surgery or Minimal-Access Surgery in Treating Patients With Bladder Cancer
Condition: Bladder Cancer
Interventions: Other: questionnaire administration;   Procedure: quality-of-life assessment;   Procedure: robot-assisted laparoscopic surgery;   Procedure: therapeutic conventional surgery;   Procedure: therapeutic laparoscopic surgery
4 Recruiting MDSC Clinical Assay in Finding and Monitoring Cancer Cells in Blood and Urine Samples From Patients With or Without Localized or Metastatic Bladder Cancer
Conditions: No Evidence of Disease;   Stage II Bladder Cancer;   Stage III Bladder Cancer;   Stage IVA Bladder Cancer;   Stage IVB Bladder Cancer
Interventions: Other: Cytology Specimen Collection Procedure;   Other: Laboratory Biomarker Analysis
5 Recruiting Chemoradiation for Bladder Preservation in Patients With Muscle Invasive Bladder Carcinoma After Complete Response to Neoadjuvant Chemotherapy
Conditions: Bladder Cancer;   Bladder Carcinoma;   Transition Cell Cancer;   Muscle Invasive Bladder Carcinoma
Interventions: Procedure: Transurethral Resection of the Bladder Tumor & Cystoscopy;   Drug: Cisplatin;   Drug: Gemcitabine;   Radiation: Intensity Modulated Radiation Therapy;   Behavioral: Quality of Life Questionnaires;   Genetic: Urine Collection for Molecular Analysis;   Genetic: Blood Collection for Molecular Analysis
6 Unknown  Quality of Life in Patients With Bladder Cancer
Condition: Bladder Cancer
Interventions: Procedure: quality-of-life assessment;   Procedure: questionnaire administration
7 Unknown  Different Factors Affecting Patients With Newly Diagnosed Bladder Cancer
Condition: Bladder Cancer
Interventions: Drug: selenium;   Drug: vitamin E;   Procedure: biopsy;   Procedure: chemoprevention;   Procedure: cryopreservation;   Procedure: cytology specimen collection procedure;   Procedure: diagnostic procedure;   Procedure: gene expression analysis;   Procedure: immunohistochemistry staining method;   Procedure: laboratory biomarker analysis;   Procedure: medical chart review;   Procedure: mutation analysis;   Procedure: polymerase chain reaction;   Procedure: quality-of-life assessment;   Procedure: questionnaire administration;   Procedure: study of socioeconomic and demographic variables
8 Recruiting 3 Tesla MRI in Patients With Bladder Cancer
Condition: Bladder Cancer
Interventions: Procedure: Specimen Ultra-High field MRI;   Drug: chemotherapy;   Procedure: Cystectomy and Lymphadenectomy
9 Unknown  Effect of Dietary, Lifestyle, and Environmental Factors on Patients With Early-Stage Bladder Cancer
Condition: Bladder Cancer
Interventions: Procedure: medical chart review;   Procedure: questionnaire administration;   Procedure: study of socioeconomic and demographic variables
10 Unknown  Selenium and Vitamin E in Preventing Cancer Progression and Recurrence in Patients With Early-Stage Bladder Cancer
Condition: Bladder Cancer
Interventions: Drug: selenium;   Drug: vitamin E;   Procedure: chemoprevention
11 Unknown  A Study for Treatment of Superficial Bladder Cancer Using OGX-427
Condition: Bladder Cancer
Intervention: Drug: OGX-427
12 Unknown  Screening for Bladder Cancer
Condition: Bladder Cancer
Intervention: Other: Specimen and questionnaires only
13 Recruiting VPM1002BC in Recurrent Non-muscle Invasive Bladder Cancer
Condition: Bladder Cancer
Intervention: Drug: VPM1002BC
14 Recruiting Improving Clinical Staging for Muscle Invasive Bladder Cancer Through Molecular Profiling and Improved Imaging
Condition: Bladder Cancer
Interventions: Procedure: Tissue Biopsy;   Procedure: Magnetic Resonance Imaging (MRI)
15 Recruiting Surgery With or Without Postoperative Intensity Modulated Radiation Therapy in Treating Patients With Urothelial Bladder Cancer
Conditions: Stage III Bladder Cancer;   Stage IV Bladder Cancer
Interventions: Other: No radiation;   Radiation: Intensity-Modulated Radiation Therapy
16 Recruiting Biomarker Identification for Bladder Cancer Patients
Condition: Bladder Cancer
Intervention: Procedure: Sample Collection
17 Unknown  Hyperthermia and Mitomycin C, Bacillus Calmette-Guerin, or Standard Therapy as Second-Line Therapy in Treating Patients With Recurrent Bladder Cancer
Condition: Bladder Cancer
Interventions: Biological: BCG solution;   Biological: recombinant interferon alfa;   Drug: epirubicin hydrochloride;   Drug: mitomycin C;   Other: laboratory biomarker analysis;   Procedure: hyperthermia treatment;   Procedure: quality-of-life assessment
18 Unknown  Genetic Susceptibility to Bladder Cancer
Conditions: Bladder Cancer;   Healthy
Intervention: Other: Specimens, personal and follow-up telephone interviews
19 Recruiting MRI in Clinical Staging and Estimation of Treatment Response in Bladder Cancer
Condition: Bladder Cancer
Intervention: Device: MR imaging
20 Recruiting Risk of Bladder Cancer in Type 2 Diabetes Patients With Pioglitazone Therapy "PROBE"
Condition: Bladder Cancer
Intervention: Drug: Pioglitazone

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years